[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100607103":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":13,"studyPopulation":13,"armGroups":20,"interventions":29,"overallOfficials":13,"centralContacts":35,"locations":41,"responsibleParty":54,"collaborators":13,"id":58,"slug":13,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":13,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":13,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":13,"overallStatus":44,"whyStopped":13,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Alexandria University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"improvement of tinea capitis","cure of tinea capitis","3 months",null,{"allocation":15,"interventionModel":16,"interventionModelDescription":13,"primaryPurpose":17,"observationalModel":13,"timePerspective":13,"maskingInfo":18},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":19,"maskingDescription":13,"whoMasked":13},"NONE",[21,26],{"label":22,"type":23,"description":13,"interventionNames":24},"Group A will receive itraconazole continuous daily regimen","ACTIVE_COMPARATOR",[25],"Drug: Itraconazole (ITZ)",{"label":27,"type":23,"description":13,"interventionNames":28},"Group B will receive itraconazole pulse regimen",[25],[30],{"type":31,"name":32,"description":33,"armGroupLabels":34,"otherNames":13},"DRUG","Itraconazole (ITZ)","therapy for tinea capitis orally",[22,27],[36],{"name":37,"role":38,"phone":39,"phoneExt":13,"email":40},"Marina K Aioub","CONTACT","00201223805043","marinaaioub10@gmail.com",[42],{"facility":43,"status":44,"city":45,"state":13,"zip":13,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":13},"Faculty of Medicine","RECRUITING","Alexandria","Egypt","EG",{"type":49,"coordinates":50},"Point",[51,52],29.91582,31.20176,{"lat":52,"lon":51},{"type":55,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":13,"oldOrganization":13},"PRINCIPAL_INVESTIGATOR","Marina Aioub","general practitioner","100607103",false,"NCT07184203","Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children","Comparative Clinicomycologic and Dermoscopic Study Between Daily and Pulse Therapy of Oral Itraconazole in Tinea Capitis in Children","Inclusion Criteria:\n\n• Tinea capitis patients with ages ranging from 5 to 18 year\n\nExclusion Criteria:\n\n* Patients with contraindications to itraconazole\n* Patients with associated scalp disease.\n* Patients weighing less than 20 Kg.","ALL","5 Years","18 Years",{"count":68,"type":69},120,"ESTIMATED","INTERVENTIONAL",[72],"NA","A study to compare the efficacy of daily therapy versus pulse therapy of oral itraconazole in the treatment of tinea capitis in children based on clinical, mycological and dermoscopic evaluation.",[75],"Tinea Capitis","2025-09-14",{"date":78,"type":79},"2025-09-19","ACTUAL",{"date":81,"type":79},"2025-03-09",{"date":83,"type":69},"2025-12-31",{"name":5,"class":6},1]